This was the stock's third consecutive day of losses.

DuPont de Nemours Inc. closed $14.98 short of its 52-week high ($90.06), which the company achieved on September 27th.

Nitrous oxide dates back to the 1840s and has been misused for its euphoric properties since early days, but it's seeing ...

Argus keeps a Buy rating and $85 price target on DuPont (DD) while noting that the stock’s recent weakness is offering a buying opportunity.

Nemours Children’s Health is investing $130 million in 2025 to expand services for maternal and fetal health, cancer, and cardiology in Delaware. The plans represent Nemours’ largest single-year ...

Wilmington, Delaware-based DuPont de Nemours, Inc. (DD) provides technology-based materials and solutions. With a market cap of $32.4 billion, the company offers a diverse range of products ...

Nemours Children's Health will invest $130 million next year to expand its Advanced Delivery Program and Neonatal Intensive Care Unit, as well as renovate the original Alfred I. duPont Institute ...

Nemours hospital helps Orlando baby born at 24 weeks beat the odds 40% chance of survival: Nemours helps baby born at 24 weeks beat odds Read full article: 40% chance of survival: Nemours helps ...

Nemours Children’s Health plans to expand its pediatric hospital and develop two new facilities on its Lake Nona campus, spending $300 million in Central Florida during the next four years, the ...

In the latest quarter, 6 analysts provided ratings for DuPont de Nemours DD, showcasing a mix of bullish and bearish perspectives. Summarizing their recent assessments, the table below illustrates ...

Nemours Children's Health is investing $300 million in central Florida over the next four years and $130 million in Delaware in 2025. In Orlando, Fla., the health system's plans include three new ...

Nemours said it is the pediatric health system's largest one-year capital investment in Delaware in its 85-year history. Nemours Children's Health unveiled plans Tuesday to invest $130 million at ...